The rising burden of lung cancer cases worldwide is driving significant advancements in therapeutic innovation. Increasing adoption of precision medicine, immunotherapy, and targeted treatment approaches is reshaping the treatment landscape for patients diagnosed with non-small cell lung cancer. Healthcare providers and pharmaceutical companies are investing heavily in research activities to...